GLP-1 RAs produce significant weight loss in adults without diabetes, with newer treatments showing greater results

An updated systematic reappraisal evaluating the efficacy and information of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and coagonists among adults with overweight oregon obesity without diabetes recovered that, among presently disposable treatments, tirzepatide produced the top value loss, portion newer experimental drugs showed adjacent larger effects.